SAN DIEGO — Sydnexis Inc., a clinical stage biopharmaceutical company focused on the treatment of progressive myopia in children and minimizing the...
sponsored content August 15, 2023 Myopia is the most common eye disease in children and has experienced a dramatic increase in prevalence...